Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 13, 2021

SELL
$2.09 - $3.09 $22,049 - $32,599
-10,550 Closed
0 $0
Q1 2020

Apr 23, 2020

SELL
$1.9 - $4.98 $1,900 - $4,980
-1,000 Reduced 8.66%
10,550 $26,000
Q4 2019

Feb 05, 2020

BUY
$3.95 - $5.35 $3,950 - $5,350
1,000 Added 9.48%
11,550 $59,000
Q3 2019

Oct 18, 2019

BUY
$4.13 - $6.94 $35,311 - $59,337
8,550 Added 427.5%
10,550 $44,000
Q2 2019

Aug 01, 2019

BUY
$3.98 - $6.2 $7,960 - $12,400
2,000 New
2,000 $12,000

Others Institutions Holding TCRT

About Alaunos Therapeutics, Inc.


  • Ticker TCRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,182,000
  • Market Cap $443M
  • Description
  • Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...
More about TCRT
Track This Portfolio

Track Coastal Investment Advisors, Inc. Portfolio

Follow Coastal Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.